Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Cost of Revenue: 2022-2024

Historic Cost of Revenue for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to $2.7 million.

  • Immunocore Holdings' Cost of Revenue rose 14.51% to $513,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 4.34%. This contributed to the annual value of $2.7 million for FY2024, which is 163.36% up from last year.
  • Immunocore Holdings' Cost of Revenue amounted to $2.7 million in FY2024, which was up 163.36% from $1.0 million recorded in FY2023.
  • In the past 5 years, Immunocore Holdings' Cost of Revenue ranged from a high of $2.7 million in FY2024 and a low of $1.0 million during FY2023.
  • For the 3-year period, Immunocore Holdings' Cost of Revenue averaged around $1.6 million, with its median value being $1.1 million (2022).
  • In the last 5 years, Immunocore Holdings' Cost of Revenue declined by 4.78% in 2023 and then soared by 163.36% in 2024.
  • Yearly analysis of 3 years shows Immunocore Holdings' Cost of Revenue stood at $1.1 million in 2022, then dropped by 4.78% to $1.0 million in 2023, then skyrocketed by 163.36% to $2.7 million in 2024.